▶ 調査レポート

世界のがん治療用温熱療法システム市場インサイト・予測(~2027年)

• 英文タイトル:Global Hyperthermia Cancer Treatment Systems Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。世界のがん治療用温熱療法システム市場インサイト・予測(~2027年) / Global Hyperthermia Cancer Treatment Systems Market Insights and Forecast to 2027 / QY2108PAL3900資料のイメージです。• レポートコード:QY2108PAL3900
• 出版社/出版日:QYResearch / 2021年8月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料はがん治療用温熱療法システムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。がん治療用温熱療法システムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(局所温熱療法システム、全身温熱療法システム)、用途別市場規模(乳がん、肝臓がん、軟部肉腫、頭頸部腫瘍、前立腺がん、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・がん治療用温熱療法システムの世界市場概要
・メーカー別の競争状況、市場シェア
・がん治療用温熱療法システムの種類別市場規模:局所温熱療法システム、全身温熱療法システム
・がん治療用温熱療法システムの用途別市場規模:乳がん、肝臓がん、軟部肉腫、頭頸部腫瘍、前立腺がん、その他
・北米のがん治療用温熱療法システム市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのがん治療用温熱療法システム市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのがん治療用温熱療法システム市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のがん治療用温熱療法システム市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのがん治療用温熱療法システム市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:PYREXAR Medical、Celsius43 GmbH、Hydrosun GmbH、Oncotherm Kft.、Andromedic S.r.l.、Yamamoto Vinita Co. Ltd、Chongqing Haifu Medical Technology Co. Ltd.、innoMedicus Ltd.、Gamida-Cell Ltd.、RanD、Gentherm
・がん治療用温熱療法システムのバリューチェーン・販売チャネル分析
・がん治療用温熱療法システムの世界市場動向

Hyperthermia Cancer Treatment is used to treat cancers. It is divided into local hyperthermia system and whole body hyperthermia system.

Market Analysis and Insights: Global Hyperthermia Cancer Treatment Systems Market
The global Hyperthermia Cancer Treatment Systems market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Hyperthermia Cancer Treatment Systems Scope and Segment
Hyperthermia Cancer Treatment Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hyperthermia Cancer Treatment Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Local Hyperthermia System
Whole Body Hyperthermia System

Segment by Application
Breast Cancer
Liver Cancer
Soft Tissue Sarcoma
Head & Neck Tumors
Prostate Cancer
Others

By Company
PYREXAR Medical
Celsius43 GmbH
Hydrosun GmbH
Oncotherm Kft.
Andromedic S.r.l.
Yamamoto Vinita Co. Ltd
Chongqing Haifu Medical Technology Co. Ltd.
innoMedicus Ltd.
Gamida-Cell Ltd.
RanD
Gentherm

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Hyperthermia Cancer Treatment Systems Product Introduction
1.2 Market by Type
1.2.1 Global Hyperthermia Cancer Treatment Systems Market Size Growth Rate by Type
1.2.2 Local Hyperthermia System
1.2.3 Whole Body Hyperthermia System
1.3 Market by Application
1.3.1 Global Hyperthermia Cancer Treatment Systems Market Size Growth Rate by Application
1.3.2 Breast Cancer
1.3.3 Liver Cancer
1.3.4 Soft Tissue Sarcoma
1.3.5 Head & Neck Tumors
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Hyperthermia Cancer Treatment Systems Sales Estimates and Forecasts 2016-2027
2.2 Global Hyperthermia Cancer Treatment Systems Revenue Estimates and Forecasts 2016-2027
2.3 Global Hyperthermia Cancer Treatment Systems Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Hyperthermia Cancer Treatment Systems Regions by Sales
2.4.1 Global Top Hyperthermia Cancer Treatment Systems Regions by Sales (2016-2021)
2.4.2 Global Top Hyperthermia Cancer Treatment Systems Regions by Sales (2022-2027)
2.5 Global Top Hyperthermia Cancer Treatment Systems Regions by Revenue
2.5.1 Global Top Hyperthermia Cancer Treatment Systems Regions by Revenue (2016-2021)
2.5.2 Global Top Hyperthermia Cancer Treatment Systems Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Hyperthermia Cancer Treatment Systems Sales by Manufacturers
3.1.1 Global Top Hyperthermia Cancer Treatment Systems Manufacturers by Sales (2016-2021)
3.1.2 Global Top Hyperthermia Cancer Treatment Systems Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Hyperthermia Cancer Treatment Systems Sales in 2020
3.2 Global Hyperthermia Cancer Treatment Systems Revenue by Manufacturers
3.2.1 Global Top Hyperthermia Cancer Treatment Systems Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Hyperthermia Cancer Treatment Systems Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Hyperthermia Cancer Treatment Systems Revenue in 2020
3.3 Global Hyperthermia Cancer Treatment Systems Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hyperthermia Cancer Treatment Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hyperthermia Cancer Treatment Systems Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Hyperthermia Cancer Treatment Systems Sales by Type
4.1.1 Global Hyperthermia Cancer Treatment Systems Historical Sales by Type (2016-2021)
4.1.2 Global Hyperthermia Cancer Treatment Systems Forecasted Sales by Type (2022-2027)
4.1.3 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2016-2027)
4.2 Global Hyperthermia Cancer Treatment Systems Revenue by Type
4.2.1 Global Hyperthermia Cancer Treatment Systems Historical Revenue by Type (2016-2021)
4.2.2 Global Hyperthermia Cancer Treatment Systems Forecasted Revenue by Type (2022-2027)
4.2.3 Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2016-2027)
4.3 Global Hyperthermia Cancer Treatment Systems Price by Type
4.3.1 Global Hyperthermia Cancer Treatment Systems Price by Type (2016-2021)
4.3.2 Global Hyperthermia Cancer Treatment Systems Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Hyperthermia Cancer Treatment Systems Sales by Application
5.1.1 Global Hyperthermia Cancer Treatment Systems Historical Sales by Application (2016-2021)
5.1.2 Global Hyperthermia Cancer Treatment Systems Forecasted Sales by Application (2022-2027)
5.1.3 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2016-2027)
5.2 Global Hyperthermia Cancer Treatment Systems Revenue by Application
5.2.1 Global Hyperthermia Cancer Treatment Systems Historical Revenue by Application (2016-2021)
5.2.2 Global Hyperthermia Cancer Treatment Systems Forecasted Revenue by Application (2022-2027)
5.2.3 Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2016-2027)
5.3 Global Hyperthermia Cancer Treatment Systems Price by Application
5.3.1 Global Hyperthermia Cancer Treatment Systems Price by Application (2016-2021)
5.3.2 Global Hyperthermia Cancer Treatment Systems Price Forecast by Application (2022-2027)

6 North America
6.1 North America Hyperthermia Cancer Treatment Systems Market Size by Type
6.1.1 North America Hyperthermia Cancer Treatment Systems Sales by Type (2016-2027)
6.1.2 North America Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2027)
6.2 North America Hyperthermia Cancer Treatment Systems Market Size by Application
6.2.1 North America Hyperthermia Cancer Treatment Systems Sales by Application (2016-2027)
6.2.2 North America Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2027)
6.3 North America Hyperthermia Cancer Treatment Systems Market Size by Country
6.3.1 North America Hyperthermia Cancer Treatment Systems Sales by Country (2016-2027)
6.3.2 North America Hyperthermia Cancer Treatment Systems Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Hyperthermia Cancer Treatment Systems Market Size by Type
7.1.1 Europe Hyperthermia Cancer Treatment Systems Sales by Type (2016-2027)
7.1.2 Europe Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2027)
7.2 Europe Hyperthermia Cancer Treatment Systems Market Size by Application
7.2.1 Europe Hyperthermia Cancer Treatment Systems Sales by Application (2016-2027)
7.2.2 Europe Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2027)
7.3 Europe Hyperthermia Cancer Treatment Systems Market Size by Country
7.3.1 Europe Hyperthermia Cancer Treatment Systems Sales by Country (2016-2027)
7.3.2 Europe Hyperthermia Cancer Treatment Systems Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Hyperthermia Cancer Treatment Systems Market Size by Type
8.1.1 Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Type (2016-2027)
8.1.2 Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2027)
8.2 Asia Pacific Hyperthermia Cancer Treatment Systems Market Size by Application
8.2.1 Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Application (2016-2027)
8.2.2 Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2027)
8.3 Asia Pacific Hyperthermia Cancer Treatment Systems Market Size by Region
8.3.1 Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Region (2016-2027)
8.3.2 Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Hyperthermia Cancer Treatment Systems Market Size by Type
9.1.1 Latin America Hyperthermia Cancer Treatment Systems Sales by Type (2016-2027)
9.1.2 Latin America Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2027)
9.2 Latin America Hyperthermia Cancer Treatment Systems Market Size by Application
9.2.1 Latin America Hyperthermia Cancer Treatment Systems Sales by Application (2016-2027)
9.2.2 Latin America Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2027)
9.3 Latin America Hyperthermia Cancer Treatment Systems Market Size by Country
9.3.1 Latin America Hyperthermia Cancer Treatment Systems Sales by Country (2016-2027)
9.3.2 Latin America Hyperthermia Cancer Treatment Systems Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Hyperthermia Cancer Treatment Systems Market Size by Type
10.1.1 Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Type (2016-2027)
10.1.2 Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2027)
10.2 Middle East and Africa Hyperthermia Cancer Treatment Systems Market Size by Application
10.2.1 Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Application (2016-2027)
10.2.2 Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2027)
10.3 Middle East and Africa Hyperthermia Cancer Treatment Systems Market Size by Country
10.3.1 Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Country (2016-2027)
10.3.2 Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 PYREXAR Medical
11.1.1 PYREXAR Medical Corporation Information
11.1.2 PYREXAR Medical Overview
11.1.3 PYREXAR Medical Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 PYREXAR Medical Hyperthermia Cancer Treatment Systems Product Description
11.1.5 PYREXAR Medical Recent Developments
11.2 Celsius43 GmbH
11.2.1 Celsius43 GmbH Corporation Information
11.2.2 Celsius43 GmbH Overview
11.2.3 Celsius43 GmbH Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Celsius43 GmbH Hyperthermia Cancer Treatment Systems Product Description
11.2.5 Celsius43 GmbH Recent Developments
11.3 Hydrosun GmbH
11.3.1 Hydrosun GmbH Corporation Information
11.3.2 Hydrosun GmbH Overview
11.3.3 Hydrosun GmbH Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Hydrosun GmbH Hyperthermia Cancer Treatment Systems Product Description
11.3.5 Hydrosun GmbH Recent Developments
11.4 Oncotherm Kft.
11.4.1 Oncotherm Kft. Corporation Information
11.4.2 Oncotherm Kft. Overview
11.4.3 Oncotherm Kft. Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Oncotherm Kft. Hyperthermia Cancer Treatment Systems Product Description
11.4.5 Oncotherm Kft. Recent Developments
11.5 Andromedic S.r.l.
11.5.1 Andromedic S.r.l. Corporation Information
11.5.2 Andromedic S.r.l. Overview
11.5.3 Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Product Description
11.5.5 Andromedic S.r.l. Recent Developments
11.6 Yamamoto Vinita Co. Ltd
11.6.1 Yamamoto Vinita Co. Ltd Corporation Information
11.6.2 Yamamoto Vinita Co. Ltd Overview
11.6.3 Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Product Description
11.6.5 Yamamoto Vinita Co. Ltd Recent Developments
11.7 Chongqing Haifu Medical Technology Co. Ltd.
11.7.1 Chongqing Haifu Medical Technology Co. Ltd. Corporation Information
11.7.2 Chongqing Haifu Medical Technology Co. Ltd. Overview
11.7.3 Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Product Description
11.7.5 Chongqing Haifu Medical Technology Co. Ltd. Recent Developments
11.8 innoMedicus Ltd.
11.8.1 innoMedicus Ltd. Corporation Information
11.8.2 innoMedicus Ltd. Overview
11.8.3 innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Product Description
11.8.5 innoMedicus Ltd. Recent Developments
11.9 Gamida-Cell Ltd.
11.9.1 Gamida-Cell Ltd. Corporation Information
11.9.2 Gamida-Cell Ltd. Overview
11.9.3 Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Product Description
11.9.5 Gamida-Cell Ltd. Recent Developments
11.10 RanD
11.10.1 RanD Corporation Information
11.10.2 RanD Overview
11.10.3 RanD Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 RanD Hyperthermia Cancer Treatment Systems Product Description
11.10.5 RanD Recent Developments
11.11 Gentherm
11.11.1 Gentherm Corporation Information
11.11.2 Gentherm Overview
11.11.3 Gentherm Hyperthermia Cancer Treatment Systems Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Gentherm Hyperthermia Cancer Treatment Systems Product Description
11.11.5 Gentherm Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Hyperthermia Cancer Treatment Systems Value Chain Analysis
12.2 Hyperthermia Cancer Treatment Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hyperthermia Cancer Treatment Systems Production Mode & Process
12.4 Hyperthermia Cancer Treatment Systems Sales and Marketing
12.4.1 Hyperthermia Cancer Treatment Systems Sales Channels
12.4.2 Hyperthermia Cancer Treatment Systems Distributors
12.5 Hyperthermia Cancer Treatment Systems Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hyperthermia Cancer Treatment Systems Industry Trends
13.2 Hyperthermia Cancer Treatment Systems Market Drivers
13.3 Hyperthermia Cancer Treatment Systems Market Challenges
13.4 Hyperthermia Cancer Treatment Systems Market Restraints

14 Key Findings in The Global Hyperthermia Cancer Treatment Systems Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Hyperthermia Cancer Treatment Systems Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Local Hyperthermia System
Table 3. Major Manufacturers of Whole Body Hyperthermia System
Table 4. Global Hyperthermia Cancer Treatment Systems Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Hyperthermia Cancer Treatment Systems Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Hyperthermia Cancer Treatment Systems Sales by Region (2016-2021) & (Units)
Table 7. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Region (2016-2021)
Table 8. Global Hyperthermia Cancer Treatment Systems Sales by Region (2022-2027) & (Units)
Table 9. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Region (2022-2027)
Table 10. Global Hyperthermia Cancer Treatment Systems Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Region (2016-2021)
Table 12. Global Hyperthermia Cancer Treatment Systems Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Region (2022-2027)
Table 14. Global Hyperthermia Cancer Treatment Systems Sales by Manufacturers (2016-2021) & (Units)
Table 15. Global Hyperthermia Cancer Treatment Systems Sales Share by Manufacturers (2016-2021)
Table 16. Global Hyperthermia Cancer Treatment Systems Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Hyperthermia Cancer Treatment Systems Revenue Share by Manufacturers (2016-2021)
Table 18. Hyperthermia Cancer Treatment Systems Price by Manufacturers 2016-2021 (K US$/Unit)
Table 19. Global Hyperthermia Cancer Treatment Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Hyperthermia Cancer Treatment Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperthermia Cancer Treatment Systems as of 2020)
Table 21. Hyperthermia Cancer Treatment Systems Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hyperthermia Cancer Treatment Systems Product Offered
Table 23. Date of Manufacturers Enter into Hyperthermia Cancer Treatment Systems Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hyperthermia Cancer Treatment Systems Sales by Type (2016-2021) & (Units)
Table 26. Global Hyperthermia Cancer Treatment Systems Sales by Type (2022-2027) & (Units)
Table 27. Global Hyperthermia Cancer Treatment Systems Sales Share by Type (2016-2021)
Table 28. Global Hyperthermia Cancer Treatment Systems Sales Share by Type (2022-2027)
Table 29. Global Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Hyperthermia Cancer Treatment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Hyperthermia Cancer Treatment Systems Revenue Share by Type (2016-2021)
Table 32. Global Hyperthermia Cancer Treatment Systems Revenue Share by Type (2022-2027)
Table 33. Hyperthermia Cancer Treatment Systems Price by Type (2016-2021) & (K US$/Unit)
Table 34. Global Hyperthermia Cancer Treatment Systems Price Forecast by Type (2022-2027) & (K US$/Unit)
Table 35. Global Hyperthermia Cancer Treatment Systems Sales by Application (2016-2021) & (Units)
Table 36. Global Hyperthermia Cancer Treatment Systems Sales by Application (2022-2027) & (Units)
Table 37. Global Hyperthermia Cancer Treatment Systems Sales Share by Application (2016-2021)
Table 38. Global Hyperthermia Cancer Treatment Systems Sales Share by Application (2022-2027)
Table 39. Global Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Hyperthermia Cancer Treatment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Hyperthermia Cancer Treatment Systems Revenue Share by Application (2016-2021)
Table 42. Global Hyperthermia Cancer Treatment Systems Revenue Share by Application (2022-2027)
Table 43. Hyperthermia Cancer Treatment Systems Price by Application (2016-2021) & (K US$/Unit)
Table 44. Global Hyperthermia Cancer Treatment Systems Price Forecast by Application (2022-2027) & (K US$/Unit)
Table 45. North America Hyperthermia Cancer Treatment Systems Sales by Type (2016-2021) & (Units)
Table 46. North America Hyperthermia Cancer Treatment Systems Sales by Type (2022-2027) & (Units)
Table 47. North America Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Hyperthermia Cancer Treatment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Hyperthermia Cancer Treatment Systems Sales by Application (2016-2021) & (Units)
Table 50. North America Hyperthermia Cancer Treatment Systems Sales by Application (2022-2027) & (Units)
Table 51. North America Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Hyperthermia Cancer Treatment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Hyperthermia Cancer Treatment Systems Sales by Country (2016-2021) & (Units)
Table 54. North America Hyperthermia Cancer Treatment Systems Sales by Country (2022-2027) & (Units)
Table 55. North America Hyperthermia Cancer Treatment Systems Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Hyperthermia Cancer Treatment Systems Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Hyperthermia Cancer Treatment Systems Sales by Type (2016-2021) & (Units)
Table 58. Europe Hyperthermia Cancer Treatment Systems Sales by Type (2022-2027) & (Units)
Table 59. Europe Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Hyperthermia Cancer Treatment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Hyperthermia Cancer Treatment Systems Sales by Application (2016-2021) & (Units)
Table 62. Europe Hyperthermia Cancer Treatment Systems Sales by Application (2022-2027) & (Units)
Table 63. Europe Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Hyperthermia Cancer Treatment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Hyperthermia Cancer Treatment Systems Sales by Country (2016-2021) & (Units)
Table 66. Europe Hyperthermia Cancer Treatment Systems Sales by Country (2022-2027) & (Units)
Table 67. Europe Hyperthermia Cancer Treatment Systems Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Hyperthermia Cancer Treatment Systems Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Type (2016-2021) & (Units)
Table 70. Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Type (2022-2027) & (Units)
Table 71. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Application (2016-2021) & (Units)
Table 74. Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Application (2022-2027) & (Units)
Table 75. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Region (2016-2021) & (Units)
Table 78. Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Region (2022-2027) & (Units)
Table 79. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Hyperthermia Cancer Treatment Systems Sales by Type (2016-2021) & (Units)
Table 82. Latin America Hyperthermia Cancer Treatment Systems Sales by Type (2022-2027) & (Units)
Table 83. Latin America Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Hyperthermia Cancer Treatment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Hyperthermia Cancer Treatment Systems Sales by Application (2016-2021) & (Units)
Table 86. Latin America Hyperthermia Cancer Treatment Systems Sales by Application (2022-2027) & (Units)
Table 87. Latin America Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Hyperthermia Cancer Treatment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Hyperthermia Cancer Treatment Systems Sales by Country (2016-2021) & (Units)
Table 90. Latin America Hyperthermia Cancer Treatment Systems Sales by Country (2022-2027) & (Units)
Table 91. Latin America Hyperthermia Cancer Treatment Systems Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Hyperthermia Cancer Treatment Systems Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Type (2016-2021) & (Units)
Table 94. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Type (2022-2027) & (Units)
Table 95. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Application (2016-2021) & (Units)
Table 98. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Application (2022-2027) & (Units)
Table 99. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Country (2016-2021) & (Units)
Table 102. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Country (2022-2027) & (Units)
Table 103. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Country (2022-2027) & (US$ Million)
Table 105. PYREXAR Medical Corporation Information
Table 106. PYREXAR Medical Description and Major Businesses
Table 107. PYREXAR Medical Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 108. PYREXAR Medical Hyperthermia Cancer Treatment Systems Product
Table 109. PYREXAR Medical Recent Developments
Table 110. Celsius43 GmbH Corporation Information
Table 111. Celsius43 GmbH Description and Major Businesses
Table 112. Celsius43 GmbH Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 113. Celsius43 GmbH Hyperthermia Cancer Treatment Systems Product
Table 114. Celsius43 GmbH Recent Developments
Table 115. Hydrosun GmbH Corporation Information
Table 116. Hydrosun GmbH Description and Major Businesses
Table 117. Hydrosun GmbH Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 118. Hydrosun GmbH Hyperthermia Cancer Treatment Systems Product
Table 119. Hydrosun GmbH Recent Developments
Table 120. Oncotherm Kft. Corporation Information
Table 121. Oncotherm Kft. Description and Major Businesses
Table 122. Oncotherm Kft. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 123. Oncotherm Kft. Hyperthermia Cancer Treatment Systems Product
Table 124. Oncotherm Kft. Recent Developments
Table 125. Andromedic S.r.l. Corporation Information
Table 126. Andromedic S.r.l. Description and Major Businesses
Table 127. Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 128. Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Product
Table 129. Andromedic S.r.l. Recent Developments
Table 130. Yamamoto Vinita Co. Ltd Corporation Information
Table 131. Yamamoto Vinita Co. Ltd Description and Major Businesses
Table 132. Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 133. Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Product
Table 134. Yamamoto Vinita Co. Ltd Recent Developments
Table 135. Chongqing Haifu Medical Technology Co. Ltd. Corporation Information
Table 136. Chongqing Haifu Medical Technology Co. Ltd. Description and Major Businesses
Table 137. Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 138. Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Product
Table 139. Chongqing Haifu Medical Technology Co. Ltd. Recent Developments
Table 140. innoMedicus Ltd. Corporation Information
Table 141. innoMedicus Ltd. Description and Major Businesses
Table 142. innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 143. innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Product
Table 144. innoMedicus Ltd. Recent Developments
Table 145. Gamida-Cell Ltd. Corporation Information
Table 146. Gamida-Cell Ltd. Description and Major Businesses
Table 147. Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 148. Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Product
Table 149. Gamida-Cell Ltd. Recent Developments
Table 150. RanD Corporation Information
Table 151. RanD Description and Major Businesses
Table 152. RanD Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 153. RanD Hyperthermia Cancer Treatment Systems Product
Table 154. RanD Recent Developments
Table 155. Gentherm Corporation Information
Table 156. Gentherm Description and Major Businesses
Table 157. Gentherm Hyperthermia Cancer Treatment Systems Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2016-2021)
Table 158. Gentherm Hyperthermia Cancer Treatment Systems Product
Table 159. Gentherm Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Hyperthermia Cancer Treatment Systems Distributors List
Table 163. Hyperthermia Cancer Treatment Systems Customers List
Table 164. Hyperthermia Cancer Treatment Systems Market Trends
Table 165. Hyperthermia Cancer Treatment Systems Market Drivers
Table 166. Hyperthermia Cancer Treatment Systems Market Challenges
Table 167. Hyperthermia Cancer Treatment Systems Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Hyperthermia Cancer Treatment Systems Product Picture
Figure 2. Global Hyperthermia Cancer Treatment Systems Market Share by Type in 2020 & 2027
Figure 3. Local Hyperthermia System Product Picture
Figure 4. Whole Body Hyperthermia System Product Picture
Figure 5. Global Hyperthermia Cancer Treatment Systems Market Share by Application in 2020 & 2027
Figure 6. Breast Cancer
Figure 7. Liver Cancer
Figure 8. Soft Tissue Sarcoma
Figure 9. Head & Neck Tumors
Figure 10. Prostate Cancer
Figure 11. Others
Figure 12. Hyperthermia Cancer Treatment Systems Report Years Considered
Figure 13. Global Hyperthermia Cancer Treatment Systems Sales 2016-2027 (Units)
Figure 14. Global Hyperthermia Cancer Treatment Systems Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hyperthermia Cancer Treatment Systems Revenue 2016-2027 (US$ Million)
Figure 16. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 17. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Region (2016-2021)
Figure 18. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Region (2022-2027)
Figure 19. North America Hyperthermia Cancer Treatment Systems Sales YoY (2016-2027) & (Units)
Figure 20. North America Hyperthermia Cancer Treatment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Europe Hyperthermia Cancer Treatment Systems Sales YoY (2016-2027) & (Units)
Figure 22. Europe Hyperthermia Cancer Treatment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Hyperthermia Cancer Treatment Systems Sales YoY (2016-2027) & (Units)
Figure 24. Asia-Pacific Hyperthermia Cancer Treatment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Latin America Hyperthermia Cancer Treatment Systems Sales YoY (2016-2027) & (Units)
Figure 26. Latin America Hyperthermia Cancer Treatment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Middle East & Africa Hyperthermia Cancer Treatment Systems Sales YoY (2016-2027) & (Units)
Figure 28. Middle East & Africa Hyperthermia Cancer Treatment Systems Revenue YoY (2016-2027) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Hyperthermia Cancer Treatment Systems Sales in 2020
Figure 30. The Top 10 and Top 5 Players Market Share by Hyperthermia Cancer Treatment Systems Revenue in 2020
Figure 31. Hyperthermia Cancer Treatment Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 32. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2016-2027)
Figure 33. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2016-2027)
Figure 34. Global Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2016-2027)
Figure 35. Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2016-2027)
Figure 36. North America Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2016-2027)
Figure 37. North America Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2016-2027)
Figure 38. North America Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2016-2027)
Figure 39. North America Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2016-2027)
Figure 40. North America Hyperthermia Cancer Treatment Systems Sales Share by Country (2016-2027)
Figure 41. North America Hyperthermia Cancer Treatment Systems Revenue Share by Country (2016-2027)
Figure 42. United States Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 43. Canada Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 44. Europe Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2016-2027)
Figure 45. Europe Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2016-2027)
Figure 46. Europe Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2016-2027)
Figure 47. Europe Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2016-2027)
Figure 48. Europe Hyperthermia Cancer Treatment Systems Sales Share by Country (2016-2027)
Figure 49. Europe Hyperthermia Cancer Treatment Systems Revenue Share by Country (2016-2027)
Figure 50. Germany Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 51. France Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 52. U.K. Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 53. Italy Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 54. Russia Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 55. Asia Pacific Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2016-2027)
Figure 56. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2016-2027)
Figure 57. Asia Pacific Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2016-2027)
Figure 58. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2016-2027)
Figure 59. Asia Pacific Hyperthermia Cancer Treatment Systems Sales Share by Region (2016-2027)
Figure 60. Asia Pacific Hyperthermia Cancer Treatment Systems Revenue Share by Region (2016-2027)
Figure 61. China Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 62. Japan Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 63. South Korea Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 64. India Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 65. Australia Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 66. Taiwan Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 67. Indonesia Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 68. Thailand Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 69. Malaysia Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 70. Latin America Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2016-2027)
Figure 71. Latin America Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2016-2027)
Figure 72. Latin America Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2016-2027)
Figure 73. Latin America Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2016-2027)
Figure 74. Latin America Hyperthermia Cancer Treatment Systems Sales Share by Country (2016-2027)
Figure 75. Latin America Hyperthermia Cancer Treatment Systems Revenue Share by Country (2016-2027)
Figure 76. Mexico Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 77. Brazil Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 78. Argentina Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 79. Colombia Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 80. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2016-2027)
Figure 82. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2016-2027)
Figure 84. Middle East and Africa Hyperthermia Cancer Treatment Systems Sales Share by Country (2016-2027)
Figure 85. Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue Share by Country (2016-2027)
Figure 86. Turkey Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 87. Saudi Arabia Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 88. UAE Hyperthermia Cancer Treatment Systems Revenue (2016-2027) & (US$ Million)
Figure 89. Hyperthermia Cancer Treatment Systems Value Chain
Figure 90. Hyperthermia Cancer Treatment Systems Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed